It is reported that angiotensin converting enzyme 2 serves as the target receptor of SARS-CoV-2 and RAASi may be associated with reduced mortality in COVID-19, however there are no consistent conclusions among different studies (Gnanenthiran et al., 2022; Wang et al., 2022). The gene discussed is ACE2; the disease is COVID-19.